David Feltquate serves as Executive at iTeos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Feltquate has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2025 involved transacting 47,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 29, 2025 | ITOS | $0 | Tender | 47,000 | $N/A | Discretionary |
David Feltquate currently holds 0 shares of iTeos Therapeutics, Inc. (ITOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Feltquate has been a net neutral trader of ITOS stock. They have purchased $0 and sold $0 worth of shares.
David Feltquate's most recent insider trade was on Aug 29, 2025, when they sold 47,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted